<DOC>
	<DOC>NCT02278107</DOC>
	<brief_summary>A preliminary study to evaluate a new nasal interface and portable ventilator system in comparison to standard oxygen therapy in patients with severe chronic lung disease.</brief_summary>
	<brief_title>Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease</brief_title>
	<detailed_description>An open-label, randomized, controlled, crossover study in patients with severe chronic lung disease to evaluate exercise tolerance compared to standard nasal cannula oxygen therapy.</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Lung Diseases, Interstitial</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Adult male or female (&gt; 18 years of age) with a diagnosis of severetovery severe chronic lung disease Participates in a qualified pulmonary rehabilitation program Requires constant flow oxygen of â‰¥ 2 LPM (liters per minute) during exercise Able and willing to sign the informed consent Ability to be fitted with the test nasal mask and to use the test ventilator system Requires &gt; 5LPM of constant flow to maintain SpO2&gt; 90% during exercise Reports having serious epistaxis within the last 14 days prior to enrollment Currently enrolled in another clinical study or has participated within 30 days of enrollment Has any condition or abnormality that in the opinion of the Investigators may compromise the participant's safety or the quality of the study data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>